Pharmaceutical

SciRhom secures $70m for autoimmune diseases treatments

SciRhom has secured €63m ($70m) in a Series A funding round to develop iRhom2-targeting therapeutics for autoimmune diseases.

Jul 10, 2024 - 04:00
SciRhom secures $70m for autoimmune diseases treatments
SciRhom has secured €63m ($70m) in a Series A funding round to develop iRhom2-targeting therapeutics for autoimmune diseases.
Read the original article

Tags:

Previous Article

Roche relaunches refillable wet AMD implant two years after recall

Next Article

Taiho exercises option for Arcus Biosciences’ quemliclustat in Asia

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: David Liu startup to focus on getting CRISPR therapy to hard-to-reach cells

STAT+: David Liu startup to focus on getting CRISPR the...

Sep 18, 2023

STAT+: Hospital-insurer tussle in Arizona puts care denials front and center

STAT+: Hospital-insurer tussle in Arizona puts care den...

May 15, 2023

Freeline touts positive data for Gaucher disease therapy  

Freeline touts positive data for Gaucher disease therapy  

May 11, 2024